Arrhythmia Monitoring Devices Market Classifications and Trends Over Forecast Report to 2025

The global arrhythmia monitoring devices market size is expected to reach USD 8.41 billion in 2025 with a CAGR of 6.8% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.

Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.

Arrhythmia-Monitoring-Devices-Market.jpg

In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market

Further key findings from the report suggest:
  • The arrhythmia monitoring devices market is highly competitive and is rapidly evolving with numerous potential market players
  • Holter monitors dominated the market in terms of revenue in 2017. On the other hand, mobile cardiac telemetry is expected to witness the fastest growth rate during the forecast period
  • Atrial fibrillation dominated the market in terms of revenue in 2017. The growth in the number of untreated cases of arrhythmias are leading to increasing need for advanced cardiac monitoring devices
  • Heightened adoption of sophisticated technologies has led to the expansion of the market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm for conditions such as atrial fibrillation
  • The hospitals and clinics segment held the largest share in the market in 2017. On the other hand, diagnostic centers are likely to experience the fastest growth over the forecast period
  • North America commanded the leading share in the market in 2017 due to faster regulatory approvals for innovative devices and procedures
  • AliveCor, Inc.; Applied Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; Fukuda Denshi Co., Ltd.; GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical (Abbott); Medtronic; Nihon Kohden Corporation; Nuubo; and Spacelabs Healthcare are some of the key players operating in this market.
Browse More Reports in Medical Devices:
Grand View Research has segmented the global arrhythmia monitoring devices market based on type, application, end use, and region:
Arrhythmia Monitoring Devices Type Outlook (Revenue, USD Million, 2014 - 2025)
  • ECG Monitors
  • Implantable Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
Arrhythmia Monitoring Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation
  • Ventricular Fibrillation
  • Premature Contraction
  • Others
Arrhythmia Monitoring Devices End Use Outlook (Revenue, USD Million, 2014 - 2025)
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others
Arrhythmia Monitoring Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
Access Press Release of This Research Report by Grand View Research:www.grandviewresearch.com/press-release/global-arrhythmia-monitoring-devices-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Comments

Post a Comment

Popular posts from this blog

Matcha Market Is Anticipated to Attain Around $5.07 Billion By 2025

Image
San Francisco, 29 April 2019 – “ Matcha Market Analysis By Grade (Ceremonial, Classic, Culinary), By Application (Regular Tea, Matcha Beverages, Food, Personal Care), By Region, And Segment Forecasts, [2018 - 2025] ” The global matcha market is expected to reach USD 5.07 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases has augmented the demand for healthy and nutrient-rich food & beverage alternatives. Anti-oxidant and vitamin-rich composition of matcha tea has fueled the product demand across the globe. Anti-oxidants, including epigallocatechin gallate (EGCG), prevent diseases such as cancer, Type-2 diabetes, cardiovascular problems. EGCG present in the product can repair DNA damage caused by UV radiation and controls the proliferation of cancerous cells. The product also has the potential to reduce stress and promotes a state of relaxation. L-theanine present in the product acts in a synergistic way to activa...
Read more

Levulinic acid Market Strategy, Distributors & Manufacturing Cost Analysis Till 2020

Image
Global  levulinic acid market  demand was 2,606.2 tons in 2013 and is projected to be 3,820 tons by 2020. The increasing application of levulinic acid, especially in pesticides, solvents, pharmaceuticals, and cosmetics industries are anticipated to boost growth in the coming years. Over the past few years, the chemical industry has continually been striving towards attaining a sustainable growth, with a focus on the development of renewable biotechnological and bio-based products. The production technology for bio-based levulinic acid has been simplified by dehydration of biomass or carbohydrates with acid. Levulinic acid is being increasingly used as a substitute to its synthetic counterparts in industrial usage. Levulinic acid market volume share by application, 2013 The global levulinic acid market is anticipated to reach USD 19.65 million revenue, with a growing CAGR of 4.8% by 2020. Increasing usage of the acid in niche applications including plastics, nyl...
Read more

Endoscopy Devices Market Chances To Reach $17.19 Billion By 2025

Image
  The global  endoscopes market  size is expected to reach USD 17.19 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.8% during the forecast period. Growing global geriatric population, high prevalence of gastrointestinal diseases, and rising technological advancements are the key factors contributing to market growth. Rising preference for minimally invasive surgeries (MIS) is also positively influencing the growth of the market. Endoscopy surgeries are performed for diagnosis as well as treatment of gastrointestinal, gynecological, neurological, and cardiovascular diseases. Emergence of minimally invasive alternatives to open surgeries such as laparoscopy, hysteroscopy, and colonoscopy is boosting the demand for endoscopes. Preference of MIS is increasing owing to smaller incision, reduction in postoperative complications & mortality, and lesser trauma. Furthermore, they are economically viable alternatives to...
Read more